# Bicara Therapeutics (BCAX) - Q4 2024 earnings

Reported March 27, 2025.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | Not available |
| EPS | $-0.39 | $-0.31 |

Earnings filing reader: [8-K 0002023658-25-000006](https://www.opencapital.sh/filings/0002023658-25-000006)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0002023658-25-000006.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/2023658/0002023658-25-000006-index.htm)
Periodic report: 10-K - https://www.sec.gov/Archives/edgar/data/2023658/0002023658-25-000012-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/bcax/earnings/q4-2024